Terms: = Lung cancer AND CDK6, MGC59692, 1021, Q00534, ENSG00000105810, PLSTIRE
262 results:
1. Postoperative ctDNA in indicating the recurrence risk and monitoring the effect of adjuvant therapy in surgical non-small cell lung cancer.
Tian X; Liu X; Wang K; Wang R; Li Y; Qian K; Wang T; Zhao X; Liu L; Zhang PL; Xiong Y; Rui J; Chen R; Zhang Y
Thorac Cancer; 2024 Apr; 15(10):797-807. PubMed ID: 38409945
[TBL] [Abstract] [Full Text] [Related]
2. Radiologic patterns of distant organ metastasis in advanced breast cancer patients: Prospective review of computed tomography images.
Jimah BB; Amoako E; Ofori EO; Akakpo PK; Aniakwo LA; Ulzen-Appiah K; Imbeah EG; Morna MT; Koggoh P; Akligoh H; Tackie R; Manu A; Paemka L; Sarkodie BD; Offei AK; Hutchful D; Ngoi J; Bediako Y; Rahman GA
Cancer Rep (Hoboken); 2024 Feb; 7(2):e1988. PubMed ID: 38351553
[TBL] [Abstract] [Full Text] [Related]
3. MAFF confers vulnerability to cisplatin-based and ionizing radiation treatments by modulating ferroptosis and cell cycle progression in lung adenocarcinoma.
Liang J; Bi G; Huang Y; Zhao G; Sui Q; Zhang H; Bian Y; Yin J; Wang Q; Chen Z; Zhan C
Drug Resist Updat; 2024 Mar; 73():101057. PubMed ID: 38266355
[TBL] [Abstract] [Full Text] [Related]
4. Discovery of (R)-4-(8-methoxy-2-methyl-1-(1-phenylethy)-1H-imidazo[4,5-c]quinnolin-7-yl)-3,5-dimethylisoxazole as a potent and selective BET inhibitor for treatment of acute myeloid leukemia (AML) guided by FEP calculation.
Yu S; Zhang Y; Yang J; Xu H; Lan S; Zhao B; Luo M; Ma X; Zhang H; Wang S; Shen H; Zhang Y; Xu Y; Li R
Eur J Med Chem; 2024 Jan; 263():115924. PubMed ID: 37992518
[TBL] [Abstract] [Full Text] [Related]
5. cdk6 is a novel predictive and prognosis biomarker correlated with immune infiltrates in multiple human neoplasms, including small cell lung carcinoma.
Li GS; Huang ZG; Li DM; Tang YL; Zheng JH; Yang L; Feng Y; Peng JX; Li JX; Tang YX; Zeng NY; Jin MH; Tian J; Liu J; Zhou HF; Chen G; Chen F
Funct Integr Genomics; 2023 Nov; 23(4):332. PubMed ID: 37950078
[TBL] [Abstract] [Full Text] [Related]
6. Dual network analysis of transcriptome data for discovery of new therapeutic targets in non-small cell lung cancer.
Bai Y; Zhou L; Zhang C; Guo M; Xia L; Tang Z; Liu Y; Deng S
Oncogene; 2023 Dec; 42(49):3605-3618. PubMed ID: 37864031
[TBL] [Abstract] [Full Text] [Related]
7. Prognostic and predictive impact of molecular tumor burden index in non-small cell lung cancer patients.
Yang F; Tang M; Cui L; Bai J; Yu J; Gao J; Nie X; Li X; Xia X; Yi X; Zhang P; Li L
Thorac Cancer; 2023 Nov; 14(31):3097-3107. PubMed ID: 37724484
[TBL] [Abstract] [Full Text] [Related]
8. Targeting FGFRs by pemigatinib induces G1 phase cell cycle arrest, cellular stress and upregulation of tumor suppressor microRNAs.
Pace A; Scirocchi F; Napoletano C; Zizzari IG; Po A; Megiorni F; Asquino A; Pontecorvi P; Rahimi H; Marchese C; Ferretti E; Nuti M; Rughetti A
J Transl Med; 2023 Sep; 21(1):626. PubMed ID: 37715207
[TBL] [Abstract] [Full Text] [Related]
9. SETD2 variation correlates with tumor mutational burden and MSI along with improved response to immunotherapy.
Zheng X; Lin J; Xiong J; Guan Y; Lan B; Li Y; Gao X; Fei Z; Chen L; Chen L; Chen L; Chen G; Guo Z; Yi X; Cao W; Ai X; Zhou C; Li X; Zhao J; Yan X; Yu Q; Si L; Chen Y; Chen C
BMC Cancer; 2023 Jul; 23(1):686. PubMed ID: 37479966
[TBL] [Abstract] [Full Text] [Related]
10. The RNA-binding protein LRPPRC promotes resistance to CDK4/6 inhibition in lung cancer.
Zhou W; Wang W; Liang Y; Jiang R; Qiu F; Shao X; Liu Y; Fang L; Ni M; Yu C; Zhao Y; Huang W; Li J; Donovan MJ; Wang L; Ni J; Wang D; Fu T; Feng J; Wang X; Tan W; Fang X
Nat Commun; 2023 Jul; 14(1):4212. PubMed ID: 37452037
[TBL] [Abstract] [Full Text] [Related]
11. Detecting undetectable - epidemiology, etiology, and diagnosis of carcinoma of unknown primary - systematic review.
Ostojewska J; Wieczorek I; Pachciński O; Zdziennicki W; Burdan F
Folia Med Cracov; 2023 Apr; 63(1):19-37. PubMed ID: 37406274
[TBL] [Abstract] [Full Text] [Related]
12. Dexamethasone induces cancer mitigation and irreversible senescence in lung cancer cells via damaging cortical actin and sustained hyperphosphorylation of pRb.
Srivastava S; Siddiqui S; Singh S; Chowdhury S; Upadhyay V; Sethi A; Kumar Trivedi A
Steroids; 2023 Oct; 198():109269. PubMed ID: 37394085
[TBL] [Abstract] [Full Text] [Related]
13. Patlak-Ki derived from ultra-high sensitivity dynamic total body [
Wang D; Qiu B; Liu Q; Xia L; Liu S; Zheng C; Liu H; Mo Y; Zhang X; Hu Y; Zheng S; Zhou Y; Fu J; Chen N; Liu F; Zhou R; Guo J; Fan W; Liu H
Eur J Nucl Med Mol Imaging; 2023 Sep; 50(11):3400-3413. PubMed ID: 37310427
[TBL] [Abstract] [Full Text] [Related]
14. A two-stage genome-wide association study identified four potential early-onset nonsmall cell lung cancer risk loci based on 26,652 participants in Chinese population.
Fan J; Hong T; Zhao X; Liang S; Zhu M; Jiang Y; Jin G; Hu Z; Ma H; Dai J; Shen H
Mol Carcinog; 2023 Sep; 62(9):1263-1270. PubMed ID: 37232355
[TBL] [Abstract] [Full Text] [Related]
15. An eleven-gene risk model associated with lymph node metastasis predicts overall survival in lung adenocarcinoma.
Zhao Y; Shi W; Tang Q
Sci Rep; 2023 Apr; 13(1):6852. PubMed ID: 37100777
[TBL] [Abstract] [Full Text] [Related]
16. Dasatinib in combination with BMS-754807 induce synergistic cytotoxicity in lung cancer cells through inhibiting lung cancer cell growth, and inducing autophagy as well as cell cycle arrest at the G1 phase.
Zhang C; Zhao X; Wang Z; Gong T; Zhao H; Zhang D; Niu Y; Li X; Zhao X; Li G; Dong X; Zhang L; Liu C; Xu J; Yu B
Invest New Drugs; 2023 Jun; 41(3):438-452. PubMed ID: 37097369
[TBL] [Abstract] [Full Text] [Related]
17. Carcinogenic effect of arsenic in digestive cancers: a systematic review.
Kasmi S; Moser L; Gonvers S; Dormond O; Demartines N; Labgaa I
Environ Health; 2023 Apr; 22(1):36. PubMed ID: 37069631
[TBL] [Abstract] [Full Text] [Related]
18. Palbociclib and Michael-acceptor hybrid compounds as CDK4/6 covalent inhibitors: Improved potency, broad anticancer spectrum and overcoming drug resistance.
Fang L; Chu M; Yan C; Liu Y; Zhao Z
Bioorg Med Chem; 2023 Apr; 84():117263. PubMed ID: 37011445
[TBL] [Abstract] [Full Text] [Related]
19. Pharmacological inhibition of EZH2 by ZLD1039 suppresses tumor growth and pulmonary metastasis in melanoma cells in vitro and in vivo.
Zhu Y; Zhang L; Song X; Zhang Q; Wang T; Xiao H; Yu L
Biochem Pharmacol; 2023 Apr; 210():115493. PubMed ID: 36898415
[TBL] [Abstract] [Full Text] [Related]
20. [Study on the Biological Function of Abemecilib in Inhibiting the Proliferation, Invasion and
Migration of Small Cell lung cancer with High c-Myc Expression].
Guo J; Mu D; Yu W; Sun L; Zhang J; Ren X; Han Y
Zhongguo Fei Ai Za Zhi; 2023 Feb; 26(2):105-112. PubMed ID: 36872049
[TBL] [Abstract] [Full Text] [Related]
[Next]
